Literature DB >> 17077668

Absence of blood and lymphatic vessels in the developing human cornea.

Claus Cursiefen1, Carmen Rummelt, Anselm Jünemann, Christian Vorwerk, Winfried Neuhuber, Friedrich E Kruse, Falk Schroedl.   

Abstract

PURPOSE: The normal human cornea is devoid of both blood and lymphatic vessels and actively maintains this avascularity (corneal angiogenic privilege). Whether and when corneal angiogenic privilege is achieved during development is unknown.
METHODS: This study analyzed whether the cornea is primarily devoid of both blood and lymphatic vessels during intrauterine development or whether secondary regression of pre-existing vessels occurs before delivery. Indirect double immunohistochemistry was performed on 4-microm serial pupil-optic disc sections of paraffin-embedded human eyes stillborn at gestational ages of 17 to 41 weeks with antibodies against von Willebrand factor (vWF; factor VIII-associated antigen) as a panendothelial marker and with antibodies against lymphatic vessel endothelial hyaluronate receptor 1 (LYVE1) as a marker specific for lymphatic vascular endothelium.
RESULTS: Human corneas were devoid of both vWF+++/LYVE-1(-) blood vessels and vWF+/LYVE-1+++ lymphatic vessels at all time-points analyzed. In contrast, there were numerous blood and lymphatic vessels detectable in the adjacent conjunctiva.
CONCLUSION: The normal human cornea is primarily avascular and devoid of both blood and lymphatic vessels. Corneal angiogenic privilege is already achieved very early during fetal intrauterine development. This suggests early and strong expression of both antiangiogenic and antilymphangiogenic factors in the human cornea during development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077668     DOI: 10.1097/01.ico.0000214230.21238.3d

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  12 in total

1.  Features of corneal neovascularization and lymphangiogenesis induced by different etiological factors in mice.

Authors:  Weiyun Shi; Chunping Ming; Juncai Liu; Ting Wang; Hua Gao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-17       Impact factor: 3.117

Review 2.  [Inhibition of angiogenesis in the anterior chamber of the eye].

Authors:  F Bock; Y König; T Dietrich; P Zimmermann; M Baier; C Cursiefen
Journal:  Ophthalmologe       Date:  2007-04       Impact factor: 1.059

3.  Spontaneous lymphatic vessel formation and regression in the murine cornea.

Authors:  Hui Zhang; Xuemei Hu; Julie Tse; Firehiwott Tilahun; Mengsheng Qiu; Lu Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-21       Impact factor: 4.799

Review 4.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

5.  Resveratrol, an Inhibitor Binding to VEGF, Restores the Pathology of Abnormal Angiogenesis in Retinopathy of Prematurity (ROP) in Mice: Application by Intravitreal and Topical Instillation.

Authors:  Wei-Hui Hu; Xiao-Yong Zhang; Ka-Wing Leung; Ran Duan; Ting-Xia Tina Dong; Qi-Wei Qin; Karl Wah-Keung Tsim
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

6.  Allergic conjunctivitis renders CD4(+) T cells resistant to t regulatory cells and exacerbates corneal allograft rejection.

Authors:  N J Reyes; P W Chen; J Y Niederkorn
Journal:  Am J Transplant       Date:  2013-03-13       Impact factor: 8.086

7.  Feasibility study of lamellar keratoplasty in a murine model.

Authors:  Ting Huang; Stephen R Planck; James T Rosenbaum; Ellen J Lee
Journal:  Ocul Immunol Inflamm       Date:  2009 Jul-Aug       Impact factor: 3.070

8.  Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains.

Authors:  Shintaro Nakao; Kazuichi Maruyama; Souska Zandi; Mark I Melhorn; Mahdi Taher; Kousuke Noda; Eyad Nusayr; Tom Doetschman; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2009-10-26       Impact factor: 5.191

9.  Lymphatics and lymphangiogenesis in the eye.

Authors:  Shintaro Nakao; Ali Hafezi-Moghadam; Tatsuro Ishibashi
Journal:  J Ophthalmol       Date:  2012-03-05       Impact factor: 1.909

10.  Effect of subconjuctival and intraocular bevacizumab injection on angiogenic gene expression levels in a mouse model of corneal neovascularization.

Authors:  Olga Dratviman-Storobinsky; Bat-Chen R Avraham-Lubin; Murat Hasanreisoglu; Nitza Goldenberg-Cohen
Journal:  Mol Vis       Date:  2009-11-13       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.